Search
Menu
Home
Sources
About
Contacts
Terbogrel
Terbogrel
is an
experimental drug
that has been
studied
for its
potential
to
prevent
the
vasoconstricting
and platelet-aggregating
action
of
thromboxanes
. Terbogrel is an
orally
available
thromboxane
A
2
receptor antagonist
and a
thromboxane A synthase
inhibitor
. The
drug
was
developed
by
Boehringer Ingelheim
.
A
phase 2 clinical trial
of terbogrel was discontinued due to its
induction
of
leg
pain
.
